An allergic response is a case of mistaken identity: your immune system treats a harmless substance like pollen, peanut protein, or dust mite debris as if it were a dangerous invader. What follows is a coordinated, multi-stage defense that produces symptoms ranging from a runny nose to life-threatening shock. The process unfolds in distinct phases, starting well before you ever feel a symptom.
Sensitization: The Silent First Encounter
The first time your immune system meets an allergen, nothing visible happens. No sneezing, no hives. But behind the scenes, your body is building the machinery for a future reaction. This invisible phase is called sensitization, and it can take days to weeks to complete.
It starts when an allergen crosses a barrier, whether that’s the lining of your nose, your gut wall, or your skin. Specialized immune cells called dendritic cells grab the allergen, break it into fragments, and carry those fragments to nearby lymph nodes. There, the dendritic cells present the allergen fragments to a type of white blood cell called a T helper cell. In people prone to allergies, the dendritic cells push these T cells to become a specific subtype (Th2 cells) that specializes in fighting parasites, not the bacteria or viruses the body actually encounters most often.
These Th2 cells then release chemical signals, particularly two messenger molecules called IL-4 and IL-13, that instruct B cells (another class of immune cell) to start producing a special antibody: immunoglobulin E, or IgE. Each IgE antibody is custom-built to recognize one specific allergen. Once made, these IgE antibodies circulate through your body and attach themselves to the surface of mast cells, which sit in tissues throughout your skin, airways, and gut, essentially arming them like trip wires. At this point, you’re sensitized. You feel perfectly fine, but your immune system is now primed to overreact the next time it sees that allergen.
The Immediate Reaction: Minutes After Exposure
When you encounter the allergen again, things move fast. The allergen binds to the IgE antibodies already sitting on the surface of your mast cells, linking two or more antibodies together like a bridge. This cross-linking triggers the mast cell to essentially explode its contents outward in a process called degranulation. Within seconds to minutes, the mast cell dumps pre-made chemical weapons into the surrounding tissue.
The most well-known of these chemicals is histamine. Histamine widens blood vessels (causing redness and warmth), makes them leaky (causing swelling), and irritates nerve endings (causing itching). In the airways, histamine and another released compound called prostaglandin D cause the smooth muscles around your bronchial tubes to contract, narrowing the passages and making it harder to breathe. In the nose, the same process produces congestion and a flood of mucus. In the skin, it creates hives.
This immediate phase peaks within about 15 to 30 minutes and typically begins to subside within an hour or two. Some mediators are released instantly from pre-stored granules inside the mast cell, while others are manufactured fresh after the cell is triggered, extending the window of symptoms.
The Late Phase: Hours of Lingering Inflammation
Many people assume the allergic reaction is over once the initial symptoms fade, but a second wave often follows 3 to 12 hours later. This late-phase reaction is driven not by mast cells alone but by a flood of reinforcements recruited to the site.
During the initial reaction, mast cells release chemical signals that act as homing beacons, pulling other immune cells out of the bloodstream and into the affected tissue. Eosinophils and neutrophils, two types of inflammatory white blood cells, arrive in large numbers within about four hours. T cells follow, releasing their own signals (including IL-5) that further activate eosinophils and stimulate the production of even more of them from precursors in the bone marrow.
This second wave is responsible for the prolonged stuffiness after a pollen exposure clears, the lingering wheezing hours after an asthma trigger, or the swelling that seems to get worse before it gets better. In the airways, this late-phase inflammation can cause a measurable drop in lung function. In chronic allergic conditions like asthma and eczema, repeated late-phase reactions cause cumulative tissue damage, including thickening of airway walls, excess mucus production, and scarring. IL-13 plays a central role in driving these longer-term tissue changes.
Why Allergies Persist for Years
One of the most frustrating aspects of allergies is how long they last. You might develop a peanut allergy at age two and still have it at forty. The reason lies in how the immune system stores its memory of the allergen.
Surprisingly, the body doesn’t maintain large numbers of IgE-producing memory cells directly. Instead, it stores the memory in a related but different type of cell: memory B cells that produce IgG antibodies (a more common, less reactive antibody class). When the allergen appears again, these IgG memory cells can rapidly switch over to producing IgE, rearming the mast cells. This process requires fresh signals from Th2 cells and IL-4, which is why the full allergic machinery needs to re-engage each time. But because the memory B cells are long-lived, the potential for an allergic reaction persists for years, even decades.
Studies of patients treated for parasitic infections found that allergen-specific IgE antibodies remained detectable in their blood several years after their last exposure, though at lower levels than before. This suggests that some long-lived IgE-producing cells may also survive independently in the bone marrow, providing a persistent low-level supply of the antibody.
When the Whole Body Reacts: Anaphylaxis
Most allergic reactions stay local: hives on the skin, congestion in the nose, cramping in the gut. Anaphylaxis is what happens when the reaction goes systemic, affecting two or more organ systems at once and escalating rapidly.
In anaphylaxis, massive mast cell degranulation floods the bloodstream with histamine and other mediators. Blood vessels throughout the body dilate and become leaky, causing a dramatic drop in blood pressure (systolic pressure falling below 90 mmHg or dropping more than 30% from your normal). The heart races to compensate. Airways constrict and swell, potentially cutting off breathing. The gut may cramp violently. Skin flushes, swells, and breaks out in hives. This combination of airway loss and plummeting blood pressure (a form of distributive shock) is what makes anaphylaxis lethal without rapid treatment, most commonly an injection of epinephrine.
A reaction is considered likely anaphylaxis when a known allergen exposure is followed by symptoms in at least two body systems: skin (hives, swelling), respiratory (wheezing, throat tightening), cardiovascular (low blood pressure, dizziness), or gastrointestinal (severe cramping, vomiting).
Allergic-Like Reactions Without IgE
Not every reaction that looks like an allergy follows the classic IgE pathway. Pseudo-allergic reactions can produce identical symptoms, including histamine release, hives, and even anaphylaxis-like episodes, through a completely different mechanism.
In these cases, certain substances activate mast cells directly through a receptor on their surface called MRGPRX2, bypassing IgE entirely. Unlike true allergies, these reactions can happen on the very first exposure because no prior sensitization is needed. A range of triggers can activate this receptor: components of wasp venom, certain antimicrobial peptides produced by the body itself, complement proteins (part of the innate immune system), and several medications. The antibiotic vancomycin, for example, can trigger a well-known reaction called “red man syndrome,” flushing and hives across the head and upper body, through this non-IgE route.
These pseudo-allergic reactions release the same inflammatory mediators as a true allergy, including histamine and various inflammatory proteins. The symptoms are often indistinguishable from a classic allergic reaction, which is one reason allergy testing sometimes comes back negative even when a person clearly reacts to a specific trigger.
How Common Allergies Are
Allergic conditions are strikingly common and appear to be increasing, particularly in developed countries, where roughly one in three children has at least one allergic disorder, whether that’s food allergy, eczema, allergic rhinitis, or asthma. Food allergy affects up to 8% of children and 10% of adults in the United States, though global rates vary dramatically. When only studies using objective testing (such as oral food challenges rather than self-reporting) are included, the confirmed prevalence of food allergy sits closer to 3%.
Geography and lifestyle matter. A study of South African toddlers found food allergy rates of 2.3% in urban areas versus just 0.5% in rural ones, a pattern that appears across multiple countries and supports the idea that something about modern, urban environments, whether it’s reduced microbial exposure, dietary changes, or pollution, shifts the immune system toward allergic responses. Australian infants in Melbourne showed some of the highest documented rates: 3% allergic to peanuts and nearly 9% allergic to raw egg based on food challenge testing.